FUJIFILM ANNOUNCES ADVANCEMENTS IN ENDOSCOPIC VISUALIZATION, PROMOTES EDUCATION AT DIGESTIVE DISEASE WEEK® 2018
Allendale, N.J., May 31, 2018 (Booth #1015) – FUJIFILM Medical Systems U.S.A., Inc., a leading provider of endoscopic imaging solutions, is showcasing its latest innovations at Digestive Disease Week® (DDW) 2018. The company will demonstrate its endoscopic imaging technologies at the Walter E. Washington Convention Center in Washington D.C., from June 2 – 5, 2018. For the first time, Fujifilm will exhibit its new 700 Series Endoscopes1, which feature enhancements in usability and visualization, and are compatible with ELUXEO® to provide optimal results in illumination.
“DDW 2018 is an ideal conference to debut Fujifilm’s 700 Series Endoscopes. Designed for use with our ELUXEO system, the advanced features help physicians achieve optimal diagnostic and therapeutic results in endoscopic procedures. We look forward to introducing new innovations to over 14,000 industry professionals in a few days,” said Keiichi Nagata, President, FUJIFILM Medical Systems U.S.A., Inc. – Endoscopy.
ELUXEO and 700 Series Endoscopes
Fujifilm’s 700 Series Endoscopes are equipped with CMOS chip-in-the-tip technology for noiseless and brilliant image transmission, as well as the new G7 grip for superior comfort and in daily practice. The new Flexibility Adjuster allows the stiffness of the flexible portion of the scope to be adjusted to the user’s preference. The product’s One Step Connector allows scopes to connect to the light source in just one step.
The 700 Series scope line is designed for use with Fujifilm’s ELUXEO, an endoscopic video imaging system equipped with 4-LED Multi-Light technology featuring Blue Light Imaging (BLI) and Linked Color Imaging (LCI®) special light observation modes. ELUXEO has an extended lamp life expectancy of six years and an intuitive user interface for an enhanced experience. Together, the two products support GI health professionals to achieve improved visualization in image enhanced endoscopy.
In addition to new innovations, Fujifilm is bringing opportunities to advance education to this year’s DDW. The company is hosting the following in-booth lectures at booth #1015:
Session title: Image Enhanced Endoscopy for the Detection and Characterization of Colonic Polyps
Speaker: Helmut Neumann, MD, PhD, FASGE, University Medical Center Mainz
Dates/Times: Sunday, June 3rd at 10:30 a.m. & Monday, June 4th at 10:30 a.m.
Session title: Initial Experience and Clinical Implication of the ELUXEO Imaging System
Speaker: Michael J. Bartel MD, PhD, Fox Chase Cancer Center
Dates/Times: Monday, June 4th at 12:00 p.m. & Tuesday, June 5th at 10:00 a.m.
For more information on Fujifilm’s offerings at DDW, including a list of products available to demo, please visit www.fujifilmddw.com.
1The 700 Series Endoscopes will be commercially released in the coming months.
FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women’s health imaging systems, Fujifilm has products that are ideal for any size imaging environment. The Endoscopy Division of FUJIFILM Medical Systems U.S.A., Inc. supplies high quality, technologically advanced FUJINON brand endoscopes to the medical market. TeraMedica Division delivers healthcare informatics, and is the leading provider of vendor neutral, enterprise-wide solutions for unrestricted medical image management. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information please visit www.fujimed.com and www.fujifilmendoscopy.com.
FUJIFILM Holdings Corporation in Tokyo, Japan, brings innovative solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies derived from photographic film. Its proprietary core technologies contribute to the fields of healthcare, graphic systems, highly functional materials, optical devices, digital imaging and document products. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2018, the company had global revenues of $23.0 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information, please visit: www.fujifilmholdings.com.
All product and company names herein may be trademarks of their registered owners.